Dyax Corp.
(NASDAQ : DYAX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 2.30%54.260.9%$2601.90m
JNJJohnson & Johnson 1.43%159.340.7%$1311.17m
MRKMerck & Co., Inc. -0.77%73.320.7%$1166.64m
BMYBristol-Myers Squibb Co. 1.61%56.301.0%$773.14m
LLYEli Lilly & Co. -0.93%245.571.1%$726.06m
ABBVAbbVie, Inc. 1.72%118.881.9%$593.69m
AZNAstraZeneca Plc -1.02%54.231.0%$295.20m
NVSNovartis AG 0.06%80.000.2%$175.98m
GSKGlaxoSmithKline Plc -0.53%41.250.2%$162.67m
DRNADicerna Pharmaceuticals, Inc. 0.34%38.250.3%$148.96m
VTRSViatris, Inc. 0.00%12.200.0%$142.65m
RPRXRoyalty Pharma Plc -3.16%37.650.1%$112.47m
BFRIBiofrontera, Inc. -18.67%4.270.0%$107.17m
RGENRepligen Corp. -2.21%262.886.7%$105.50m
NVONovo Nordisk A/S 0.45%107.120.1%$85.21m

Company Profile

Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA.